ConCallIQ
Go Pro
ME
MEDIASSISTHEALTHCARE Healthcare 09 May 2026

Medi Assist Healthcare Services Ltd — Q4 FY26

Medi Assist delivered a strong FY26 with operating revenue of ₹904.8 crore (+25.1% YoY) and EBITDA of ₹174.6 crore (19.3% margin).

bullish high
Revenue ₹242 Cr +25.1%
EBITDA ₹175 Cr +13.3%
PAT ₹54 Cr
EBITDA Margin 20%
Duration 60 min
Read Time 1 min read

✓ Verified against BSE filing

2-Min Summary

✦ AI-Generated from Full Transcript

Medi Assist delivered a strong FY26 with operating revenue of ₹904.8 crore (+25.1% YoY) and EBITDA of ₹174.6 crore (19.3% margin). Growth was driven by group premiums (+25.6% YoY), technology revenue (+91.9% YoY), and government business (+42.6% YoY). The company became debt-free and net cash positive. Management guided for continued strong growth in technology and international segments, with Paramount integration on track to complete by Q2 FY27. Key risk: potential compression of take rates as AI automation becomes more widespread, though management argues value-added services and outcome-based pricing will protect margins.

Key Numbers

Total Premium Under Management ₹25,923 crore
+22.8% YoY

Group premiums grew 25.6% to ₹23,000+ crore; retail premiums grew 4.2% to ₹2,818 crore.

Group Premium Retention Rate 93.2%
-1.8pp YoY

Slightly lower than historical 94%+ due to deliberate quality-of-revenue decisions and operational changes.

Market Share in Health Insurance Premium Administered 20.7%
+115bps YoY

Group segment market share reached 33.7% (+340bps YoY); retail TPA model share was 5%.

Fraud Detection Savings via Maven Guard ₹540 crore
N/A

AI fraud detection platform prevented over ₹540 crore in health insurance fraud in FY26.

Management Guidance

G

Paramount integration to complete by Q2 FY27

Over 50% of Paramount claims volume already migrated to Matrix; full migration and synergy realization expected within 1-2 quarters.

Management guidance expansion
G

Technology and international segments to sustain high growth

Management expects similar growth rates (tech ~92% YoY) to continue, driven by new pilots and global partnerships.

Management guidance growth
G

Group business growth to moderate to 8-10% same-store

Post-COVID tailwinds fading; organic growth expected to align with industry trends, supplemented by new business additions.

Management guidance revenue

Key Risks

R

Take rate compression due to AI automation

Analyst raised concern that increasing automation could reduce industry take rates from ~3.5% to 2.5% over time, pressuring revenue per premium.

medium · analyst_question
R

Slowdown in IT/ITeS sector impacting group premiums

Large corporate clients in IT are seeing no net employee addition, which could dampen group premium growth despite diversification into other industries.

medium · analyst_question
R

Integration risks from Paramount acquisition

While on track, any delays in migration or client retention could impact expected synergies and margin expansion.

low · management_commentary

Notable Quotes

We combine strong growth and deep technology transformation. Becoming debt free and net cash positive strengthens our ability to invest in the future.
Satish Gidugu · CEO and Whole Time Director
Our AI investments are paying off in creating a unified interconnected intelligence platform that we believe is going to change the way all of these stakeholders experience healthcare in a service delivery.
Satish Gidugu · CEO and Whole Time Director
The true measure of this country's success would be 100% cashless and resulting in 100% payable health insurance products rather than those products that actually focus on deductions.
Satish Gidugu · CEO and Whole Time Director

Frequently Asked Questions

What was Medi Assist Healthcare's revenue in Q4 FY26?

Medi Assist Healthcare reported revenue of ₹242 Cr in Q4 FY26, representing a +25.1% change compared to the same quarter last year.

What guidance did Medi Assist Healthcare management give for FY27?

Paramount integration to complete by Q2 FY27: Over 50% of Paramount claims volume already migrated to Matrix; full migration and synergy realization expected within 1-2 quarters. Technology and international segments to sustain high growth: Management expects similar growth rates (tech ~92% YoY) to continue, driven by new pilots and global partnerships. Group business growth to moderate to 8-10% same-store: Post-COVID tailwinds fading; organic growth expected to align with industry trends, supplemented by new business additions.

What are the key risks for Medi Assist Healthcare in FY27?

Key risks include Take rate compression due to AI automation — Analyst raised concern that increasing automation could reduce industry take rates from ~3.5% to 2.5% over time, pressuring revenue per premium.; Slowdown in IT/ITeS sector impacting group premiums — Large corporate clients in IT are seeing no net employee addition, which could dampen group premium growth despite diversification into other industries.; Integration risks from Paramount acquisition — While on track, any delays in migration or client retention could impact expected synergies and margin expansion..

Did Medi Assist Healthcare meet its previous quarter's guidance?

Scorecard data is being built as historical quarters are processed.

Where can I read the full Medi Assist Healthcare Q4 FY26 concall transcript?

The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary verified against official BSE/NSE filings.